ICU Medical (ICUI) vs Envista (NVST)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
ICU Medical (ICUI) has outperformed Envista (NVST) over the past year, gaining 32.1% versus a gain of 12.8%. Over five years, ICUI leads with a -32.4% price change compared with -40.5% for NVST. ICU Medical is the larger company by market cap ($3.90 billion vs $3.70 billion), about 1.1 times the size.
On valuation, Envista trades at a lower forward P/E (13.8x vs 16.2x for ICU Medical).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ICUI | NVST |
|---|---|---|
| Share price | $156.03 | $23.04 |
| Market cap | $3.90B | $3.70B |
| 1-day change | -2.32% | -0.99% |
| YTD return | +9.36% | +6.13% |
| 1-year return | +32.12% | +12.83% |
| 5-year return | -32.41% | -40.50% |
| P/E ratio (TTM) | 131.12 | 39.72 |
| Forward P/E | 16.18 | 13.85 |
| EPS (TTM) | $1.19 | $0.58 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $2.23B | — |
| Revenue growth (YoY) | -6.33% | — |
| Net income (latest FY) | $732.00K | — |
| Gross margin | 36.84% | — |
| Operating margin | 1.92% | — |
| Net margin | 0.03% | — |
| 52-week high | $192.85 | $30.42 |
| 52-week low | $112.50 | $18.77 |
| Distance from 52-week high | -19.09% | -24.26% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +23.94% | +28.86% |
| Average volume | 278.57K | 2.84M |
| Shares outstanding | 25.01M | 160.62M |
| Employees | 13,000 | 12,000 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ICUI has outperformed NVST by 19.3 percentage points over the past year.
- ICU Medical trades at a higher earnings multiple (131.1x vs 39.7x trailing P/E).
About ICU Medical
ICUI stock →ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products.
Health Care · Medical/Dental Instruments · 13,000 employees
About Envista
NVST stock →Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables.
Health Care · Medical/Dental Instruments · 12,000 employees
ICUI vs NVST FAQ
Which is bigger, ICU Medical or Envista?
ICU Medical (ICUI) is larger, with a market capitalization of $3.90B compared with $3.70B for Envista (NVST).
Which stock has performed better over the past year, ICUI or NVST?
ICUI returned +32.12% over the past 12 months, compared with +12.83% for NVST (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ICUI or NVST?
NVST has the lower trailing P/E at 39.7, versus 131.1 for ICUI. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are ICU Medical and Envista in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.